bucladesine has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jurd, L; Narayanan, VL; Paull, KD | 1 |
| Otte, A; Smets, LA; van der Klooster, P | 1 |
2 other study(ies) available for bucladesine and Leukemia L 1210
| Article | Year |
|---|---|
In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Bucladesine; Cell Differentiation; Dioxoles; DNA Topoisomerases, Type I; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Tubulin | 1987 |
Glucocorticoid receptors of normal and leukemic cells: role of proliferation conditions.
Topics: Animals; Binding Sites; Bucladesine; Cell Cycle; Cell Division; Cell Line; Culture Media; Dexamethasone; Humans; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocytes; Mice; Mice, Inbred DBA; Receptors, Glucocorticoid; Receptors, Steroid | 1985 |